๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Strategic use of statistical thinking in drug development

โœ Scribed by Frank W. Rockhold

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
50 KB
Volume
19
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of alternative drugs in Finland
Use of alternative drugs in Finland
โœ Taina Mรคntyranta; ELINA Hemminki; Kaj Koskela ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 1 views

Objectives ร The purpose of this study was to assess the use of alternative drugs among the adult population in Finland, especially to ยฎnd out how the health status, health behaviour and use of licensed drugs and health care services are related to the use of alternative drugs. Design ร A telephone

On the role of MRS in drug development
On the role of MRS in drug development
โœ Paul M. J. McSheehy ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 26 KB ๐Ÿ‘ 2 views

An excellent review of the role of MR in drug development was published this year in NMR in Biomedicine, and elegantly expounded upon at the recent 7th Conference of the ISMRM, Philadelphia. 1 The review discussed and presented detailed evidence of the current and potential contribution of NMR to th

The management of interim analyses in dr
The management of interim analyses in drug development
โœ Karen M. Facey; John A. Lewis ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB ๐Ÿ‘ 2 views

The ethical need for interim analyses in long-term trials of life-threatening conditions is well established, but recently there has been increased enthusiasm for the use of interim analyses in other areas of clinical research. Interim analysis is seen as a powerful tool in drug development to help

Application of genetics and genomics in
Application of genetics and genomics in drug development
โœ Mihael H. Polymeropoulos ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 2 views

Pharmacogenetics is capitalizing on the tools of the Human Genome Project to introduce the new genomic information into drug development. The applications vary from identifying individuals at risk for a disease, to developing gene signatures of drug efficacy and adverse effects. Pharmacogenetics is